⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Pasteur Institute of Iran and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Pasteur Institute of Iran
↗Tehran, Iran
The Pasteur Institute of Iran (IPI) is a leading public health and medical research institution established in 1920. It serves as a critical hub for vaccine development, biopharmaceutical production, and infectious disease surveillance in Iran and the broader West Asia region, operating as a member of the global Pasteur Network.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Vaccine Research & Development
SIZE & FINANCIALS
Employees:1001-5000
Founded:1920
Ownership:government
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:Preclinical
Modalities:Viral vectors, Vaccines, Nanobodies, Recombinant proteins
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Pasteur Network (Global alliance), Finlay Institute of Vaccines (Cuba - vaccine collaboration), WHO Collaborating Centers
COMPETITION
Position:Niche Player
Competitors:Razi Vaccine and Serum Production Research Institute, CinnaGen
LEADERSHIP
Key Executives:
Morteza Karimipoor - Director of Research, Education & Technology
LINKS
Website:pasteur.ac.ir
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Pasteur Institute of Iran. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.